Literature DB >> 3921050

Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins.

R Fleming, M J Haxton, M P Hamilton, G S McCune, W P Black, M C MacNaughton, J R Coutts.   

Abstract

Eight oligomenorrhoeic patients with increased luteinizing hormone (LH) and androgen levels who had failed to conceive during prolonged anti-oestrogen therapy received a new treatment. Large doses of an LH-releasing hormone (LHRH) analogue (HOE 766) were used to suppress circulating gonadotrophin concentrations and block the positive feedback gonadotrophin surge. Ovulation was induced during continued LHRH analogue treatment with exogenous gonadotrophins without interference from the patient's own pituitary. Seven of eight patients conceived rapidly without premature luteinization and without excessive ovarian enlargement. These complications had occurred in control treatment cycles using exogenous gonadotrophins in the absence of the LHRH analogue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921050     DOI: 10.1111/j.1471-0528.1985.tb01111.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  17 in total

1.  The uses of LH-releasing hormone and analogs in infertility.

Authors:  R Fleming; C Conaghan; J R Coutts
Journal:  Ir J Med Sci       Date:  1986-12       Impact factor: 1.568

Review 2.  Progress in ovulation induction with gonadotropins.

Authors:  P R Gindoff; R Jewelewicz
Journal:  Bull N Y Acad Med       Date:  1989-06

3.  The duration of pituitary suppression by means of intranasal gonadotropin hormone-releasing hormone analogue administration does not influence the ovarian response to gonadotropin stimulation and success rate in a gamete intrafallopian transfer (GIFT) program.

Authors:  V Remorgida; P Anserini; S Croce; M Costa; A Ferraiolo; A Centonze; G Gaggero; G L Capitanio
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-04

4.  Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients.

Authors:  M C Edelstein; R G Brzyski; G S Jones; S Oehninger; S M Sieg; S J Muasher
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-06

5.  Pretreatment with a subcutaneous gonadotropin-releasing hormone agonist in an in vitro fertilization cycle resulting in a viable pregnancy.

Authors:  A J Ferrier; A S Berkeley; I N Cholst
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-08

6.  Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments.

Authors:  J M Cummins; J M Yovich; W R Edirisinghe; J L Yovich
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-12

7.  A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program.

Authors:  N O Turhan; P G Artini; G D'Ambrogio; F Droghini; C Battaglia; A D Genazzani; A Volpe; A R Genazzani
Journal:  J Assist Reprod Genet       Date:  1993-01       Impact factor: 3.412

Review 8.  Drugs in the treatment of female infertility. Recent advances.

Authors:  M M Quigley
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

9.  Follicular aspiration does not protect against the development of ovarian hyperstimulation syndrome.

Authors:  M A Aboulghar; R T Mansour; G I Serour; I Elattar; Y Amin
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

10.  Impact of GnRH analogues on oocyte/embryo quality and embryo development in in vitro fertilization/intracytoplasmic sperm injection cycles: a case control study.

Authors:  Akos Murber; Péter Fancsovits; Nóra Ledó; Zsuzsa Tóthné Gilán; János Rigó; János Urbancsek
Journal:  Reprod Biol Endocrinol       Date:  2009-09-25       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.